Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing Revision: v3.3.1.
    Difference
    0.0%
    Check dated 2025-12-01T17:45:31.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a note that PubMed-derived publications are automatically filled for the study page and may not be about the study, and updated the revision to v3.3.1; removed the previous PubMed note and Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T14:49:40.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Deleted the generic government operating status notice from the page, which does not affect the study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-17T07:34:14.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The new screenshot shows the same study details and locations with only minor formatting or rendering differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:24:39.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Cali, Colombia, 760043 as a study location and removed Santiago de Cali, Colombia, 760043 from the locations list. This updates the Contacts and Locations section to reflect current recruitment sites.
    Difference
    0.1%
    Check dated 2025-10-26T20:47:50.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    2%
    Check dated 2025-10-05T10:12:12.000Z thumbnail image

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.